Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer

PURPOSE: We incorporated cetuximab, a chimeric monoclonal antibody against the epidermal growth factor receptor (EGFR), into the induction therapy and subsequent chemoradiotherapy of head and neck cancer (HNC). PATIENTS AND METHODS: Patients with locally advanced HNC, including squamous and undiffer...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Argiris, Athanassios, Heron, Dwight E., Smith, Ryan P., Kim, Seungwon, Gibson, Michael K., Lai, Stephen Y., Branstetter, Barton F., Posluszny, Donna M., Wang, Lin, Seethala, Raja R., Dacic, Sanja, Gooding, William, Grandis, Jennifer R., Johnson, Jonas T., Ferris, Robert L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2010
Aiheet:
Original Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018361/
https://ncbi.nlm.nih.gov/pubmed/21079141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.30.6423
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia